|
LOC100133991 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.40230000231523E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.31790000001963E-06 |
| Normal-vs-Stage2 |
1.419610E-02 |
| Normal-vs-Stage3 |
2.002600E-01 |
| Normal-vs-Stage4 |
2.205200E-01 |
| Stage1-vs-Stage2 |
3.526800E-01 |
| Stage1-vs-Stage3 |
1.123870E-02 |
| Stage1-vs-Stage4 |
7.278100E-02 |
| Stage2-vs-Stage3 |
2.171000E-01 |
| Stage2-vs-Stage4 |
3.627600E-01 |
| Stage3-vs-Stage4 |
9.338600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11830000207414E-08 |
| Normal-vs-AfricanAmerican |
8.217300E-03 |
| Normal-vs-Asian |
5.220400E-01 |
| Caucasian-vs-AfricanAmerican |
4.856100E-03 |
| Caucasian-vs-Asian |
3.803300E-03 |
| AfricanAmerican-vs-Asian |
4.890400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.6931000035878E-08 |
| Normal-vs-Female |
1.084660E-03 |
| Male-vs-Female |
6.684600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.435600E-02 |
| Normal-vs-Extreme_Weight |
1.172290E-04 |
| Normal-vs-Obese |
2.555600E-04 |
| Normal-vs-Extreme_Obese |
6.604500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.605200E-01 |
| Normal_Weight-vs-Obese |
5.161800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.763800E-01 |
| Extreme_Weight-vs-Obese |
9.206200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.361600E-01 |
| Obese-vs-Extreme_Obese |
4.796400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.039300E-03 |
| Normal-vs-Age(41-60Yrs) |
9.43929999719373E-08 |
| Normal-vs-Age(61-80Yrs) |
4.96049999998416E-06 |
| Normal-vs-Age(81-100Yrs) |
7.234400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.267200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.694400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.436000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.282000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.745500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.347380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.87380008678895E-10 |
| Normal-VS-Type2 PRCC |
3.924300E-02 |
| Normal-VS-KIRP CIMP |
5.724200E-02 |
| Normal-VS-Unclassified PRCC |
5.541500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.497400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.182100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.270400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.148200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.011400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.341200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.828000E-02 |
| Normal-vs-N1 |
5.450400E-02 |
| Normal-vs-N2 |
4.980600E-01 |
| N0-vs-N1 |
7.019000E-01 |
| N0-vs-N2 |
7.262000E-01 |
| N1-vs-N2 |
5.980800E-01 |
|
|
